Back to Search
CAMERON CRANE, MD
MD
Internal Medicine Physician
NPI: 1528696044Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
U0323(TX)
Research & Publications (20)
Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer.
PMID 19464823·Int J Radiat Oncol Biol Phys·2010
3-trial
Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411.
PMID 19636002·J Clin Oncol·2009
3-trial
Potential benefits of integration of therapies with chemoradiation in rectal cancer.
PMID 19360153·Gastrointest Cancer Res·2007
8-other
Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer.
PMID 16505434·J Clin Oncol·2006
3-trial
The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer.
PMID 12909219·Int J Radiat Oncol Biol Phys·2003
4-observational
The role of intraoperative radiotherapy in pancreatic cancer.
PMID 14989127·Surg Oncol Clin N Am·2003
6-review
Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
PMID 11955742·Int J Radiat Oncol Biol Phys·2002
8-other
Limitations of conventional doses of chemoradiation for unresectable biliary cancer.
PMID 12095564·Int J Radiat Oncol Biol Phys·2002
8-other
Toxicity and Efficacy of Concurrent Gemcitabine and Radiotherapy for Locally Advanced Pancreatic Cancer.
PMID 12754400·Int J Gastrointest Cancer·2001
8-other
Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer.
PMID 11163503·Int J Radiat Oncol Biol Phys·2001
8-other
Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index.
PMID 11510031·Semin Oncol·2001
6-review
Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head.
PMID 12540024·Int J Gastrointest Cancer·2001
3-trial
The relationship between dispositional mindfulness and conditional goal setting in depressed patients.
PMID 19558756·Br J Clin Psychol·2010
8-other
Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation.
PMID 19399614·Dig Dis Sci·2010
8-other
Is there a role for intraoperative radiation therapy in patients with resected pancreatic adenocarcinoma?
PMID 19526207·Ann Surg Oncol·2009
8-other
Dose escalation with proton or photon radiation treatment for pancreatic cancer.
PMID 19454367·Radiother Oncol·2009
8-other
Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
PMID 19646012·J Gastroenterol Hepatol·2009
8-other
Staging, prognostic factors, and therapy of localized rectal cancer.
PMID 19336008·Curr Oncol Rep·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7400 MERTON MINTER ST
SAN ANTONIO, TX 78229 - Phone
- (210) 617-5300
Quick Facts
- NPI
- 1528696044
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile